Shield Therapeutics plc
STX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £6 | £14 | £3 | £12 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £20 | £11 | £4 | £2 |
| Inventory | £5 | £3 | £1 | £2 |
| Other Curr. Assets | £0 | £4 | £2 | £2 |
| Total Curr. Assets | £30 | £31 | £10 | £17 |
| Property Plant & Equip (Net) | £0 | £1 | £0 | £0 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £15 | £17 | £12 | £27 |
| Long-Term Investments | £1 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £16 | £18 | £12 | £27 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £46 | £49 | £22 | £44 |
| Liabilities | – | – | – | – |
| Payables | £19 | £4 | £2 | £4 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £7 | £6 | £8 | -£1 |
| Total Curr. Liab. | £26 | £11 | £11 | £3 |
| LT Debt | £21 | £20 | £6 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £21 | £20 | £6 | £1 |
| Other Liabilities | £0 | £3 | £0 | -£1 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £47 | £26 | £17 | £3 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £16 | £12 | £4 | £3 |
| Retained Earnings | -£173 | -£234 | -£131 | -£79 |
| AOCI | -£6 | -£7 | -£9 | £1 |
| Other Equity | £198 | £234 | £141 | £115 |
| Total Equity | -£1 | £12 | £5 | £41 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £46 | £38 | £22 | £44 |
| Net Debt | £16 | £6 | £3 | -£12 |